Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Environ Toxicol Chem ; 39(6): 1267-1272, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32239770

RESUMEN

There is no use restriction associated with bees for many fungicides used in agriculture; however, this does not always mean that these pesticides are harmless for these nontarget organisms. We investigated whether the fungicide pyraclostrobin, which acts on fungal mitochondria, also negatively affects honey bee mitochondrial bioenergetics. Honey bees were collected from 5 hives and anesthetized at 4 °C. The thoraces were separated, and mitochondria were isolated by grinding, filtering, and differential centrifugation. An aliquot of 0.5 mg of mitochondrial proteins was added to 0.5 mL of a standard reaction medium with 4 mM succinate (complex II substrate) plus 50 nM rotenone (complex I inhibitor), and mitochondrial respiration was measured at 30 °C using a Clark-type oxygen electrode. Mitochondrial membrane potential was determined spectrofluorimetrically using safranin O as a probe, and adenosine triphosphate (ATP) synthesis was determined by chemiluminescence. Pyraclostrobin at 0 to 50 µM was tested on the mitochondrial preparations, with 3 repetitions. Pyraclostrobin inhibited mitochondrial respiration in a dose-dependent manner at concentrations of 10 µM and above, demonstrating typical inhibition of oxidative phosphorylation. Pyraclostrobin also promoted a decline in the mitochondrial membrane potential at doses of 5 µM and above and in ATP synthesis at 15 µM and above. We conclude that pyraclostrobin interferes with honey bee mitochondrial function, which is especially critical for the energy-demanding flight activity of foraging bees. Environ Toxicol Chem 2020;39:1267-1272. © 2020 SETAC.


Asunto(s)
Abejas/efectos de los fármacos , Hongos/efectos de los fármacos , Fungicidas Industriales/toxicidad , Mitocondrias/efectos de los fármacos , Estrobilurinas/toxicidad , Adenosina Trifosfato/metabolismo , Animales , Metabolismo Energético/efectos de los fármacos , Hongos/metabolismo , Fungicidas Industriales/metabolismo , Inactivación Metabólica/efectos de los fármacos , Potencial de la Membrana Mitocondrial , Mitocondrias/metabolismo , Estrobilurinas/metabolismo
2.
J Econ Entomol ; 111(3): 1369-1375, 2018 05 28.
Artículo en Inglés | MEDLINE | ID: mdl-29534200

RESUMEN

Silkworm cocoon production has been reduced due to a number of problems other than those inherent in sericulture, such as diseases, malnutrition, and inappropriate management. The use of pesticides in areas surrounding mulberry fields can contaminate these plants and consequently harm caterpillars. The aim of this study was to evaluate whether the application of the fungicide pyraclostrobin in mulberry plants interferes with the mitochondrial bioenergetics and the productive performance of silkworms. Mulberry plants were treated with pyraclostrobin (0, 100, 200, and 300 g ha-1). After 30 d of fungicide application, fifth instar caterpillars were fed with leaves from the treated plants. We evaluated in vitro and in vivo mitochondrial bioenergetics of mitochondria from the head and intestines, as well as the feed intake and mortality rate of the caterpillars and the weight of fresh cocoons and cocoons shells. At doses of 50 µM (in vitro) and 200 g ha-1 (in vivo), pyraclostrobin inhibited oxygen consumption in state 3, dissipated membrane potential, and inhibited ATP synthesis in mitochondria. Pyraclostrobin acted as a respiratory chain inhibitor, affecting mitochondrial bioenergetics. The fungicide did not interfere with food consumption but negatively affected mortality rate and weight of cocoons. Mulberry leaves contaminated with pyraclostrobin negatively impact the mitochondrial bioenergetics of silkworms and cocoon production.


Asunto(s)
Bombyx/crecimiento & desarrollo , Fungicidas Industriales/efectos adversos , Mitocondrias/metabolismo , Estrobilurinas/efectos adversos , Animales , Bombyx/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Metabolismo Energético/efectos de los fármacos , Larva/efectos de los fármacos , Larva/crecimiento & desarrollo , Mitocondrias/efectos de los fármacos , Morus/crecimiento & desarrollo
4.
J Infect Dis ; 189 Suppl 1: S153-9, 2004 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-15106104

RESUMEN

An accurate system of identifying and classifying suspected measles cases is critical for the measles surveillance system in the United States. To examine the performance of the clinical case definition in predicting laboratory confirmation of suspected cases of measles, we reviewed 4 studies conducted between 1981 and 1994. A clinical case definition was examined that included a generalized maculopapular rash, fever (>or=38.3 degrees C, if measured), and either a cough, coryza, or conjunctivitis. Serological confirmation of measles was done either by hemagglutination inhibition assay, complement fixation assay, or enzyme immunoassays. The positive predictive value of the clinical case definition decreased from 74% to 1% as incidence decreased from 171 cases/100000 population to 1.3 cases/100000 population. Sensitivity was high, and for the larger studies with the most precise estimates, sensitivity was 76%-88%. The low positive predictive value of the clinical case definition in settings of low incidence demonstrates that serological confirmation is essential to ensure an accurate diagnosis of measles when measles is rare.


Asunto(s)
Anticuerpos Antivirales/sangre , Virus del Sarampión/inmunología , Sarampión/diagnóstico , Adolescente , Región del Caribe/epidemiología , Pruebas de Fijación del Complemento , Pruebas de Inhibición de Hemaglutinación , Humanos , Técnicas para Inmunoenzimas , Inmunoglobulina M/sangre , Incidencia , Sarampión/epidemiología , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad , Suriname/epidemiología , Estados Unidos/epidemiología , Venezuela/epidemiología
5.
Vaccine ; 22(9-10): 1214-20, 2004 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-15003650

RESUMEN

The purpose of the present study was to compare serum and mucosal immune responses following either aerosol (Aer) or subcutaneous (SQ) measles immunization of Mexican school children. A cohort of 49 children from 6 to 7 years of age received either Aer ( n = 22) or SQ ( n = 27) Edmonston-Zagreb (EZ) measles vaccine. Serum and nasal secretions were collected prior to (Pre), 1 and 3 months (mos) intervals and analyzed for immunoglobulin (Ig) concentrations and measles specific Ig isotype-associated antibody by enzyme immunoassay (EIA). Serum and nasal IgG and IgA antibody responses were stimulated following immunization with live, attenuated EZ measles vaccine administered either by SQ or Aer routes but these responses were significantly greater by the Aer compared to the SQ route. These studies also suggest that the level of antibody in these secretions may serve as an important marker of immunity to measles and lend further support for aerosol immunization as an effective alternative vaccine delivery strategy for measles eradication.


Asunto(s)
Inmunidad Mucosa/inmunología , Vacuna Antisarampión/inmunología , Administración Intranasal , Aerosoles , Niño , Femenino , Humanos , Inmunización Secundaria , Inmunoglobulina A/análisis , Inmunoglobulina A/biosíntesis , Inmunoglobulina G/análisis , Inmunoglobulina G/biosíntesis , Inyecciones Subcutáneas , Masculino , Vacuna Antisarampión/efectos adversos , México
6.
Bull World Health Organ ; 82(11): 852-7, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15640921

RESUMEN

The Americas have set a goal of interrupting indigenous transmission of measles using a strategy developed by the Pan American Health Organization (PAHO). This strategy includes recommendations for vaccination activities to achieve and sustain high immunity in the population and is complemented by sensitive epidemiological surveillance systems developed to monitor illnesses characterized by febrile rash, and to provide effective virological and serological surveillance. A key component in ensuring the success of the programme has been a laboratory network comprising 22 national laboratories including reference centres. Commercially available indirect enzyme immunoassay kits (EIA) for immunoglobulin M (IgM)-class antibodies are currently being used throughout the region. However, because there are few or no true measles cases in the region, the positive predictive value of these diagnostic tests has decreased. False-positive results of IgM tests can also occur as a result of testing suspected measles cases with exanthemata caused by Parvovirus B19, rubella and Human herpesvirus 6, among others. In addition, as countries maintain high levels of vaccination activity and increased surveillance of rash and fever, the notification of febrile rash illness in recently vaccinated people can be anticipated. Thus, managers in the measles elimination programme must be prepared to address the interpretation of a positive result of a laboratory test for measles IgM when clinical and epidemiological data may indicate that the case is not measles. The interpretation of an IgM-positive test under different circumstances and the definition of a vaccine-related rash illness in a setting of greatly reduced, or absent, transmission of measles is discussed.


Asunto(s)
Programas de Inmunización , Técnicas para Inmunoenzimas/normas , Sarampión/diagnóstico , Sarampión/inmunología , Programas Nacionales de Salud , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Exantema/etiología , Humanos , Inmunoglobulina M/sangre , Sarampión/prevención & control , Sarampión/transmisión , Vacuna Antisarampión/inmunología , América del Norte/epidemiología , Organización Panamericana de la Salud , Vigilancia de la Población , Valor Predictivo de las Pruebas , América del Sur/epidemiología
7.
Emerg Infect Dis ; 8(8): 808-13, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12141966

RESUMEN

During a resurgence of measles in São Paulo, Brazil, in 1997, >40,000 cases (peak incidence rate of 246/100,000 inhabitants) and 42 measles-related deaths were reported. Reverse transcriptase-polymerase chain reaction and nucleotide sequencing were used to analyze specimens from patients who had typical clinical measles infection during this outbreak and from six patients who had had measles in 1995 and 1996. Although wild-type measles viruses (genotypes D5 and D6) were present in São Paulo before this resurgence, we detected only D6 viruses. The genotype D6 viruses isolated during this outbreak had identical sequences to genotype D6 viruses isolated in other parts of Brazil and South America in 1997 and 1998, suggesting that a single chain of transmission was responsible. We also identified genotype A viruses in two vaccine-associated cases from 1995 and 1996. Our findings extend the knowledge of the circulation patterns of measles virus in South America, contributing to measles control efforts in the Americas.


Asunto(s)
Brotes de Enfermedades , Virus del Sarampión/genética , Sarampión/epidemiología , Sarampión/virología , Brasil/epidemiología , Variación Genética , Genoma Viral , Genotipo , Humanos , Virus del Sarampión/aislamiento & purificación , Epidemiología Molecular , Filogenia , ARN Viral/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA